SHOULD THE PUBLIC SECTOR CONDUCT GENOMICS R&D?Anwar Naseem () and James F. Oehmke No 19842, 2002 Annual meeting, July 28-31, Long Beach, CA from American Agricultural Economics Association (New Name 2008: Agricultural and Applied Economics Association) Abstract: The nature of the observed market structure and R&D competition in genomics research is used as the basis for a comparative analysis of research under a mixed oligopoly, pure oligopoly and monopoly when the timing of the innovation outcome is uncertain (as in an R&D race), the winner-take-all assumption is relaxed and the profits in later stages are a function of the R&D expenditures of prior stages. The sufficient conditions under which a mixed oligopoly performs more R&D than the pure oligopoly and monopoly markets are derived and are shown to be a function of a) that public firm's objective is strictly greater than in the winning state then in the losing state, b) profits for the winning and losing private firms in the private duopoly are equal, post innovation, and c) the objective function of the firms in the mixed duopoly are increasing in research faster than they are for firms in the other two cases. It is suggested that when these conditions are met, the public firm can play a role in increasing the level of research in genomics. Keywords: Research; and; Development/Tech; Change/Emerging; Technologies (search for similar items in EconPapers) Downloads: (external link) Related works: Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text Persistent link: https://EconPapers.repec.org/RePEc:ags:aaea02:19842 Access Statistics for this paper More papers in 2002 Annual meeting, July 28-31, Long Beach, CA from American Agricultural Economics Association (New Name 2008: Agricultural and Applied Economics Association) Contact information at EDIRC. |
Is your work missing from RePEc? Here is how to contribute.
Questions or problems? Check the EconPapers FAQ or send mail to .
EconPapers is hosted by the
Örebro University School of Business.